Claudia Wellbrock

8PUBLICATIONS
18CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersMedical infection agents (incl. prions)Gene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Mar 24, 2026
Androgen receptor and fatty acid oxidation cooperate in ferroptosis evasion in BRAFi resistant melanoma.

Marta Redondo-Muñoz, Adria Caballe-Mestres, Julie A Reisz

|Aug 10, 2023
Metabolic rewiring induced by ranolazine improves melanoma responses to targeted therapy and immunotherapy.

Marta Redondo-Muñoz, Francisco Javier Rodriguez-Baena, Paula Aldaz

|Mar 08, 2020
Cooperative behaviour and phenotype plasticity evolve during melanoma progression.

Emily J Rowling, Zsofia Miskolczi, Raghavendar Nagaraju

|Jul 20, 2019
Osteoblasts contribute to a protective niche that supports melanoma cell proliferation and survival.

Jennifer Ferguson, Daniel J Wilcock, Sophie McEntegart

|Jun 19, 2019
Phenotype plasticity as enabler of melanoma progression and therapy resistance.

Imanol Arozarena, Claudia Wellbrock

|Oct 03, 2018
A PAX3/BRN2 rheostat controls the dynamics of BRAF mediated MITF regulation in MITFhigh /AXLlow melanoma.

Michael P Smith, Sareena Rana, Jennifer Ferguson

Pageof 2